|
|
Article: Vector of membrane fusogenic liposomes used for melanoma vaccine.
- Article from:
- Cancer Vaccine Week
- Article date:
- June 14, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Scientists have developed a melanoma vaccine based on the vector of membrane fusogenic liposomes.
"Membrane fusogenic liposomes can deliver encapsulated contents into the cytoplasm directly in a Sendai virus fusion-dependent manner. Based on the high delivery rates into the cytoplasm, membrane fusogenic liposomes were investigated as an antigen delivery vehicle. The membrane fusogenic liposomes were formulated by fusing simple liposomes with ultraviolet inactivated Sendai virus," scientists in China report.
"The vaccine was prepared by encapsulating mixture antigen into the simple liposomes, and then fusing ...